Mali Schneiter, DO
Gynecologic Oncology · Nashville, TNNPI 1497133938
Payments from drug & device makers
What this record shows
28 manufacturers reported payments, led by Intuitive Surgical at 39.6% of the total. 2025 is the largest year on record at $1,060, 3.3 times the $325 reported in 2021. That places this record below the midpoint for gynecologic oncology clinicians in TN, where the typical reported total is $3,700.
Across 52 payments — averaging $49.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- Medical Device Business Services, Inc.$325
- Merck$240
- Eisai Inc.$105
- Novartis$103
- Pfizer$72
- plus $724 from 22 others
What the payments were for
- Food & beverage$1,27349%
- Education$1,32551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $1,029 |
| Medical Device Business Services, Inc. | 1 | $325 |
| Merck | 8 | $240 |
| Eisai Inc. | 4 | $105 |
| Novartis | 4 | $103 |
| Pfizer | 3 | $72 |
| AbbVie | 2 | $65 |
| Bayer | 3 | $62 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Hologic Inc | 1 | $51 |
| Sanofi | 2 | $50 |
| AVEO Pharmaceuticals, Inc. | 1 | $43 |
| EMD Serono, Inc. | 2 | $41 |
| AstraZeneca | 2 | $40 |
| Puma Biotechnology, Inc. | 2 | $38 |
| Sobi, Inc | 1 | $27 |
| GSK | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Tolmar, Inc. | 1 | $24 |
| Pharmaand GmbH | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Fennec Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,000
How this compares
$2,598 in reported general payments places this provider in the 35th percentile of 40 gynecologic oncology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Nashville
- Ronald AlvarezNashville$33K
- Michael StanyNashville$13K
- Thomas NumnumNashville$8K
- Lauren PrescottNashville$7K
- Aaron NizamNashville$5K
- Stephanie SullivanNashville$5K
- Marta CrispensNashville$4K
- Courtney PennNashville$3K
- Laura WilliamsNashville$3K
- Kirsten JorgensenNashville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.